CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Jun. 01, 2017	Jun. 02, 2016
Cash flows from operating activities
Net income (loss)	$ 2,721	$ (105)
Adjustments to reconcile net income (loss) to net cash provided by operating activities
Depreciation expense and amortization of intangible assets	2,795	2,266
Amortization of debt discount and other costs	93	94
Stock-based compensation	158	148
Loss on restructure of debt	62	4
Gain on remeasurement of previously-held equity interest in Inotera	(71)	0
Equity in net (income) loss of equity method investees	(7)	(24)
Change in operating assets and liabilities
Receivables	(1,338)	468
Inventories	108	(580)
Accounts payable and accrued expenses	511	3
Payments attributed to intercompany balances with Inotera	(361)	0
Deferred income taxes, net	80	11
Other	199	(13)
Net cash provided by operating activities	4,950	2,272
Cash flows from investing activities
Expenditures for property, plant, and equipment	(3,469)	(3,894)
Acquisition of Inotera	(2,634)	0
Purchases of available-for-sale securities	(943)	(879)
Payments to settle hedging activities	(267)	(107)
Proceeds from sales and maturities of available-for-sale securities	857	3,189
Proceeds from settlement of hedging activities	146	190
Other	71	(141)
Net cash provided by (used for) investing activities	(6,239)	(1,642)
Cash flows from financing activities
Proceeds from issuance of debt	3,136	2,166
Proceeds from issuance of stock under equity plans	108	30
Proceeds from equipment sale-leaseback transactions	0	538
Repayments of debt	(1,774)	(689)
Payments on equipment purchase contracts	(261)	(14)
Cash paid to acquire treasury stock	(35)	(147)
Other	33	(181)
Net cash provided by (used for) financing activities	1,207	1,703
Effect of changes in currency exchange rates on cash and equivalents	(10)	7
Net increase (decrease) in cash and equivalents	(92)	2,340
Cash and equivalents at beginning of period	4,140	2,287
Cash and equivalents at end of period	$ 4,048	$ 4,627